Search Results - "Girroir, Elizabeth E"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice by Girroir, Elizabeth E., Hollingshead, Holly E., He, Pengfei, Zhu, Bokai, Perdew, Gary H., Peters, Jeffrey M.

    “…The expression patterns of PPARβ/δ have been described, but the majority of these data are based on mRNA data. To date, there are no reports that have…”
    Get full text
    Journal Article
  2. 2

    Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes by Borland, Michael G, Foreman, Jennifer E, Girroir, Elizabeth E, Zolfaghari, Reza, Sharma, Arun K, Amin, Shantu, Gonzalez, Frank J, Ross, A Catharine, Peters, Jeffrey M

    Published in Molecular pharmacology (01-11-2008)
    “…Although there is strong evidence that ligand activation of peroxisome proliferator-activated receptor (PPAR)-beta/delta induces terminal differentiation and…”
    Get more information
    Journal Article
  3. 3

    Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes by Burdick, Andrew D., Bility, Moses T., Girroir, Elizabeth E., Billin, Andrew N., Willson, Timothy M., Gonzalez, Frank J., Peters, Jeffrey M.

    Published in Cellular signalling (01-06-2007)
    “…The functional role of peroxisome proliferator-activated receptor-β(PPARβ; also referred to as PPARδ) in epidermal cell growth remains controversial. Recent…”
    Get full text
    Journal Article
  4. 4

    Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands do not potentiate growth of human cancer cell lines by Hollingshead, Holly E., Killins, Renee L., Borland, Michael G., Girroir, Elizabeth E., Billin, Andrew N., Willson, Timothy M., Sharma, Arun K., Amin, Shantu, Gonzalez, Frank J., Peters, Jeffrey M.

    Published in Carcinogenesis (New York) (01-12-2007)
    “…Ligands for peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) increase skeletal muscle fatty acid catabolism, improve insulin sensitivity, increase…”
    Get full text
    Journal Article
  5. 5

    Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines by Girroir, Elizabeth E, Hollingshead, Holly E, Billin, Andrew N, Willson, Timothy M, Robertson, Gavin P, Sharma, Arun K, Amin, Shantu, Gonzalez, Frank J, Peters, Jeffrey M

    Published in Toxicology (Amsterdam) (14-01-2008)
    “…Abstract The development of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands for the treatment of diseases including metabolic syndrome,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Peroxisome proliferator-activated receptor-[beta]/[delta] (PPAR[beta]/[delta]) ligands do not potentiate growth of human cancer cell lines by Hollingshead, Holly E, Killins, Renee L, Borland, Michael G, Girroir, Elizabeth E, Billin, Andrew N, Willson, Timothy M, Sharma, Arun K, Amin, Shantu, Gonzalez, Frank J, Peters, Jeffrey M

    Published in Carcinogenesis (New York) (01-12-2007)
    “…Ligands for peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) increase skeletal muscle fatty acid catabolism, improve insulin sensitivity, increase…”
    Get full text
    Journal Article